AI assistant
Sending…
NOVAVAX INC — Director's Dealing 2017
Feb 2, 2017
31982_dirs_2017-02-02_fecd1bd2-30ad-48e1-b30c-bdc965c08569.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NOVAVAX INC (NVAX)
CIK: 0001000694
Period of Report: 2017-01-31
Reporting Person: Herrmann John A III (SVP, General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-01-31 | Common Stock | P | 4960 | $1.12 | Acquired | 7072 | Direct |
Footnotes
F1: Includes 4,960 shares acquired under the Issuer's Amended and Restated 2013 Employee Stock Purchase Plan on January 31, 2017.